| Filed On | Filing |
|---|---|
| 09 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
On October 8, 2026, the board of directors of Goldenwell Biotech, Inc. (the “Company”) appointed Ming Zhou as a director. The board of directors now consists of four persons, including Shuang Liu, Yang Lee, Hua Xie and Ms. Zhou. |
| 29 Sep 2026 |
8-K: Changes in Registrant's Certifying Accountant
We have read Goldenwell Biotech, Inc’s statements included under Item 4.01 of its Form 8-K dated September 28, 2026. We agree with the statements concerning our firm under Items 4.01. |
| 27 May 2026 | 8-K: Non-Reliance on Previously Issued Financial Statements |
| 19 Aug 2025 | 8-K: Changes in Registrant's Certifying Accountant |
| 23 Jan 2025 | 8-K: Changes in Registrant's Certifying Accountant |
| 15 Nov 2024 | 8-K: Changes in Registrant's Certifying Accountant |
| 20 May 2024 | 8-K: Changes in Registrant's Certifying Accountant |
| 09 Sep 2021 | 8-K: Changes in Registrant's Certifying Accountant |
Loading...
